A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas
- 1 January 1998
- journal article
- clinical trial
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 37 (1) , 55-62
- https://doi.org/10.1023/a:1005867520788
Abstract
This study is a combined modality Phase II therapeutic trial to determine the efficacy of the novel combination of VP-16, Vincristine and Procarbazine in addition to postoperative radiation therapy...Keywords
This publication has 11 references indexed in Scilit:
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma TrialsJNCI Journal of the National Cancer Institute, 1993
- Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adultsCancer, 1993
- VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumorsJournal of Neuro-Oncology, 1990
- Does chemotherapy benefit the patient with a central nervous system glioma?1987
- Synergistic antitumor activity of vincristine and VP-16-213Cancer Chemotherapy and Pharmacology, 1984
- Etoposide (VP-16-213) in malignant brain tumors: a phase II study.Journal of Clinical Oncology, 1984
- Lack of potentiation of vincristine-induced neurotoxicity by VP-16–213American Journal of Clinical Oncology, 1983
- COMPARISONS OF CARMUSTINE, PROCARBAZINE, AND HIGH-DOSE METHYLPREDNISOLONE AS ADDITIONS TO SURGERY AND RADIOTHERAPY FOR THE TREATMENT OF MALIGNANT GLIOMA1983
- Statistical considerations for pilot studiesInternational Journal of Radiation Oncology*Biology*Physics, 1980